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An efficient synthesis of the marine metabolite 3-bromoverongiaquinol (1) and the first total synthesis of 5-monobromocavernicolin 
(2), both isolated from the marine sponge Aplysina cavernicola, have been described based on the 1,2 addition of the lithium enolate 
of N,O-bistrimethylsilylacetamide (BSA, 4) to 1,4-benzoquinone (3). Bromination and purification of the crude product on silica 
gel chromatography provided 3-bromoverongiaquinol (1) in 50% overall yield. Under alkaline conditions, the crude product of the 
bromination reaction was converted to 5-monobromocavernicolin (2) in 20% yield which was also obtained in 13% yield (25% yield 
based on recovered starting material) from 3-bromoverongiaquinol (1).
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INTRODUCTION
The invertebrates are the main source of biologically active 
natural compounds among marine organisms. Over the last 25 
years, sponges have been a privileged research topic due to the 
large number of biologically active metabolites produced by the 
gender Porifera.1 These metabolites are part of the chemical arsenal 
employed by these organisms against predators or to mark their 
territory.2 Verongida sponges attract the attention of chemists and 
biologists as natural sources of unusual fatty acids,3 steroids,4 caro-
tenoids5 and aminoacids.6 For example, from Aplysina cavernicola 
several biologically active compounds such as 3-bromoverongiaqui-
nol (1)7 and 5-monobromocavernicolin (2)8 have been isolated. In 
2002, compound 2 was also obtained from another marine sponge 
(Suberea aff. praetensa).9 
While 3-bromoverongiaquinol (1) displayed bactericidal proper-
ties against Streptococcus faecalis and Bacillus subtilis,7 5-monobro-
mocavernicolin (2) represents the first example of a marine natural 
product isolated in almost racemic form (6% ee) which was shown 
to inhibit the growth of Sarcina lutea, Bacillus subtilis, Alcaligenes 
faecalis and Proteus vulgaris.8
Racemic 3-bromoverongiaquinol (1) has been previously prepa-
red twice via anodic oxidation, albeit in very low yields (2.5 and 6.3% 
yield),7,10 and the relative configuration of 5-monobromocavernicolin 
(2) was proposed based solely on spectroscopic and mass spectrome-
try data as no total synthesis has been reported so far.8
We were attracted to the synthesis of compounds 1 and 2 not 
only because the biological profile of 5-monobromocavernicolin (2) 
remains unexplored, but also because these two compounds may rea-
sonably be biogenetically interconnected as (+/-)-2 might conceivably 
be formed via a 1,4-addition of the amide group to the less hindered 
conjugated double bond in (+/-)-1. Therefore, it was our expectation 
at the onset of this work to contribute with a synthetic route to both 
3-bromoverongiaquinol (1) and 5-monobromocavernicolin (2).
RESULTS AND DISCUSSION
The synthesis of compounds 1 and 2 was envisaged starting with 
the 1,2-addition of the lithium enolate derived from N,O-bistrimethyl-
silylacetamide (BSA, 4) to 1,4-benzoquinone (3) (Scheme 1). Our first 
attempt was based on an analogous transformation reported by Evans 
and coworkers:11 after generation of the lithium enolate of BSA (4) 
in THF at -78 ºC, the addition of 1,4-benzoquinone (3) was carried 
out at -100 ºC, to afford a mixture of silyl amide 5 (28% yield) and 
amide 6 (5% yield) after warm up to 0 ºC, aqueous acid treatment 
and purification by chromatography on silica gel (Table 1, entry 1)
By increasing the reaction temperature to room temperature after 
the addition of 1,4-benzoquinone (3) to the lithium enolate of BSA (4) 
at -100 ºC, the combined yield of amides 5 and 6 increased to 36% 
with amide 6 as the major product (Table 1, entry 2). The addition 
of DMPU or HMPA did not prove to be beneficial (Table 1, entries 
3 and 4) and the use of the sodium enolate of BSA provided neither 
amide 5 nor 6 (Table 1, entry 5). The best combined yield of amides 
5 and 6 (56%) was achieved by employing 2.0 equiv. of the lithium 
enolate of BSA and reaction temperature ranging from -100 ºC to rt, 
Figure 1. Marine metabolites (+/-)-1 and (+/-)-2
Scheme 1. Preparation of amides 5 and 6
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which afforded amide 6 as the major product in 38% yield accom-
panied by silyl amide 5 in 18% yield, after column chromatography 
on silica gel (Table 1, entry 6).
We next investigated the bromination reaction of amides 5 and 
6 in order to achieve the preparation of 3-bromoverongiaquinol (1). 
Despite being only partially soluble in CHCl
3
, each amide reacted with 
bromine at 0 ºC to rt via the dibromo derivative (+/-)-7, as revealed 
by 1H-NMR data of the crude mixture, to afford, after column chro-
matography on silica gel, 3-bromoverongiaquinol (1) in reasonable 
overall yield (67%) in both cases. Acetonitrile proved to be the best 
solvent and, after the same sequence of steps, both amides 5 and 6 
provided 3-bromoverongiaquinol (1) in 89% overall yield (Scheme 2).
To explore the preparation of 5-monobromocavernicolin (2) di-
rectly from silyl amide 5 and amide 6 (Scheme 3), their bromination 
products were treated with LDA but (+/-)-5-monobromocavernicolin 
(2) was isolated in low yield both from silyl amide 5 and from amide 
6 (Table 2, entries 1 and 2). The same poor result was observed when 
(+/-)-6 was treated with NaHMDS in THF (Table 2, entry 3). When 
the bromination products of amides 5 and 6 were treated with tert-
BuOK, only (+/-)-1 was obtained in 74% yield from both amides.
In all these attempts to obtain (+/-)-2 via the bromination-
dehydrobromination-1,4-addition sequence the main product was 
always (+/-)-3-bromoverongiaquinol (1). These results clearly pointed 
out that the use of a strong base was not appropriate to promote the 
requisite 1,4-addition, probably due to the reversible nature of this 
addition under strongly basic conditions. Then, we turned our atten-
tion to the use of DBU, a weaker base which is known to promote 
dehydrobromination to generate unsaturated ketones.12 In fact, after 
bromination of silyl amide (+/-)-5 in CH
3
CN at 0 ºC, treatment of the 
crude product with 1.0 equiv. of DBU provided (+/-)-2 in 20% overall 
yield (Table 2, entry 4) with (+/-)-1 as the major product (47% yield).
Finally, we explored the formation of 5-monobromocavernicolin 
(2) from 3-bromoverongiaquinol (1) by treating the latter compound 
in CH
3
CN with 1.0 equiv. of DBU (Scheme 4). The reaction provided 
(+/-)-2, in 13% yield (25% based on recovered starting material), 
and its regioisomer (+/-)-8 (25% yield). In spite of the competitive 
formation of (+/-)-8, this result demonstrates the feasibility of the 
conversion of (+/-)-1 to (+/-)-2 under basic conditions. 
Synthetic 5-monobromocavernicolin (2) displayed spectroscopic 
(IR, 1H- and 13C-NMR) and mass spectrum data identical to those 
reported by Pietra and coworkers8 for natural 5-monobromocaverni-
colin (2), thus confirming the assignment of its relative configuration.
EXPERIMENTAL
Instrumentation
 
1H-RMN and 13C-RMN were record on a Varian Gemini instru-
ment operating at 300 and 75 MHz, respectively, or on a Varian Inova 
instrument operating at 500 and 125 MHz, respectively. Infrared 
spectra were obtained with a Thermo Nicolet IR-200 instrument. 
Mass spectra were measured on a VG Autospec instrument using EI 
technique at 70 eV or on a QTof Ultima Waters using ESI technique. 
2-(1-Hydroxy-4-oxo-2,5-cyclohexadienyl)-N-trimethylsilyl 
acetamide (5) / 2-(1-hydroxy-4-oxo-2,5-ciclohexadienyl) 
acetamide (6)
To a flask equipped with a magnetic stirring bar, under argon 
atmosphere and at -78 ºC was added diisopropylamine (0.20 mL, 
1.41 mmol) and THF (12.0 mL). To this solution was added n-BuLi 
(2.35 M soln. in hexanes, 0.60 mL, 1.41 mmol) and after stirring 5 
min at -78 ºC, N,O-bistrimethylsilylacetamide (BSA, 0.70 mL, 2.82 
mmol) was added and stirring was maintained for 30 min at the same 
temperature. The reaction mixture was cooled to -100 ºC for the addi-
tion of a soln. of 1,4-benzoquinone (0.152 g, 1.41 mmol) in THF (5.0 
mL) and the reaction mixture was kept at -78 ºC for 3 h. The reaction 
Scheme 2. Synthesis of (+/-)-3-bromoverongiaquinol (1)
Scheme 3. Synthesis of (+/-)-5-monobromocavernicolin (2) and lactam (+/-)-8
Scheme 4. Synthesis of (+/-)-5-monobromocavernicolin (2) from 3-bromo-
verongiaquinol (1)
Table 1. Reaction conditions and yields for amides 5 and 6
Entry Base BSA (equiv.) Temperature Additive 5 (%) 6 (%)
1 LDA 1.0 -100 ºC to 0 ºC - 28 5
2 LDA 1.0 -100 ºC to rt - 4 32
3 LDA 1.0 -100 ºC to rt DMPU 6 25
4 LDA 1.0 -100 ºC to rt HMPA 5 12
5 NaHMDS 1.0 -100 ºC to rt - - -
6 LDA 2.0 -100 ºC to rt - 18 38
Table 2. Cyclization products derived from amide 5 and 6
Entry R Base 
(equiv.)
Solvent (+/-)-1 
(%)
(+/-)-2 
(%)
(+/-)-8 
(%)
1 H LDA (1.0) THF 45 4 22
2 TMS LDA (3.0) THF 23 5 12
3 H NaHMDS (1.0) THF 55 3 6
4 TMS DBU (1.0) CH
3
CN 47 20 10
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mixture was warmed up to rt, satd. NH
4
Cl soln. was added and after 
drying over MgSO
4
 and filtration through a pad of Celite, the solvent 
was removed under reduced pressure. After column chromatography 
on silica gel (ethyl acetate as eluent), 5 (0.062 g, 0.26 mmol) was 
obtained in 18% yield as a white solid (mp 101-103 ºC) and 6 (0.091 
g, 0.54 mmol) in 38% yield as a white solid (mp 114-115 ºC).
Analytical data for 2-(1-Hydroxy-4-oxo-2,5-cyclohexadienyl)-N-
trimethylsilyl acetamide (5): IR (neat, cm-1): 3359, 2952, 1682, 1404, 
1072 and 845. 1H-NMR [300 MHz, (CD
3
)
2
CO)]: δ7.19 (2H, d, J 10.3 
Hz), 6.88 (1H, br s), 6.40 (1H, br s), 6.16 (2H, d, J 10.3 Hz), 2.58 
(2H, s) and 0.13 (9H, s). 13C-NMR [75 MHz, (CD
3
)
2
CO)]: δ 185.0, 
170.0, 151.6, 127.7, 70.5, 48.8 and 1.5. HRMS (70 eV, m/z): calcd. 
for C
11
H
17
NO
3
Si - M•+ 239.09777; found: 239.09711.
Analytical data for 2-(1-hydroxy-4-oxo-2,5-ciclohexadienyl) 
acetamide (6): IR (neat, cm-1): 3359, 2929, 1660, 1622, 1402 and 
1032. 1H-NMR [300 MHz, (CD
3
)
2
CO)]: δ 7.23 (1H, br s), 7.04 (2H, 
d, J 10.3 Hz), 6.80 (1H, br s), 6.10 (1H, d, J 10.3 Hz), 5.90 (1H, s) 
and 2.61 (2H, s). 13C-NMR [75 MHz, (CD
3
)
2
CO)]: δ 184.2, 172.1, 
150.4, 126.6, 67.3 and 43.4. HRMS (70 eV, m/z): calcd. for C
8
H
9
NO
3
 
- M•+, 167.05824; found: 167.04752.
(+/-)-3-Bromoverongiaquinol (1)
A soln. of silyl amide 5 (0.022 g, 0.09 mmol) in acetonitrile (0.80 
mL) was cooled to 0 ºC when a 0.1 M soln. of bromine in CHCl
3
 
(0.90 mL, 0.090 mmol) was added. The reaction mixture was stirred 
at rt for 30 min and the solvent was removed under reduced pressure. 
The crude product was purified by column chromatography on silica 
gel (ethyl acetate as eluent) to afford (+/-)-1 (0.019 g, 0.08 mmol) 
in 89% yield as a yellowish oil. An analogous procedure provided 
(+/-)-1 from amide (+/-)-6. IR (film, cm-1): 3348, 1668, 1406, 1030, 
964 and 827. 
1H-NMR [500 MHz, (CD
3
)
2
CO]: δ 7.56 (1H, d, J 2.6 Hz), 7.20 
(1H, br s), 7.12 (1H, dd, J 10.1 and 2.7 Hz), 6.70 (1H, br s), 6.25 
(1H, d, J 10.1 Hz), 5.96 (1H, s) and 2.71 (2H, d, J 1.1 Hz). 13C-NMR 
[125 MHz, (CD
3
)
2
CO)]: δ 178.1, 172.1, 151.9, 151.8, 125.8, 123.5, 
71.0 and 43.9. HRMS (70 eV, m/z): calcd. for C
8
H
8
NO
3
Br - M•+, 
244.96876; found: 244.96901.
(+/-)-5-monobromocavernicolin (2) and 7-Bromo-3a-hydroxy-
2,3,3a,6,7,7a-hexahydro-1H-2,6-indoledione (8)
Method A: To a soln. of (+/-)-5 (0.015 g, 0.06 mmol) in acetoni-
trile (0.80 mL) cooled to 0 ºC was added dropwise a 0.1 M soln of 
bromine in CHCl
3
 (0.60 mL, 0.06 mmol). The reaction mixture was 
let to stir 30 min at rt when the solvent was removed under reduced 
pressure to provide a brown solid residue, which was dissolved in 
CH
3
CN (6.0 mL) and treated with DBU (9.0 μL, 0.06 mmol). After 
stirring 12 h at rt, a satd. soln. of NH
4
Cl was added, the mixture 
was dried over MgSO
4
 and the solvent was removed under reduced 
pressure. The residue was purified by column chromatography on 
silica gel (1:9 hexanes/ethyl acetate as eluent) to afford (+/-)-2 (2.9 
mg, 0.012 mmol) in 20% yield as a colorless solid (mp 184-185 ºC) 
together with (+/-)-1 (6.8 mg, 0.028 mmol) and (+/-)-8 (1.4 mg, 
5.7x10-3 mmol).
Method B: To a soln. of (+/-)-1 (6.8 mg, 0.028 mmol) in acetonitri-
le (3.0 mL) was added DBU (4.2 μL, 0.028 mmol). After stirring 12 h 
at rt, a satd. soln. of NH
4
Cl was added and the mixture was treated with 
anhydrous MgSO
4
. The solvent was removed under reduced pressure 
and the residue was purified by column chromatography on silica gel 
(1:9 hexanes/ethyl acetate as eluent) to afford (+/-)-2 (0.9 mg, 3.7
 
x10-3 mmol) in 13% yield [25% yield based on recovered (+/-)-1] as 
a colorless solid and (+/-)-8 (1.6 mg, 6.5
 
x10-3 mmol) in 23% yield.
Analytical data for (+/-)-5-monobromocavernicolin (2): IR (neat, 
cm-1): 3438, 2922, 2852, 1689, 1410, 1331, 1051, 1026, 1001, 825 and 
764. 1H-NMR [300 MHz, (CD
3
)
2
CO]: δ 7.29 (1H, br s), 7.09 (1H, br 
s), 5.38 (1H, br s), 4.14 (1H, br t), 3.04 (1H, dd, J 16.4 and 4.8 Hz), 
2.68 (1H, d, J 16.7 Hz) and 2.58 (1H, d, J 16.7 Hz). 1H-NMR [500 
MHz, CD
3
OD]: δ 7.27 (1H, br s), 4.08 (1H, br t), 3.05 (1H, dd, J 16.5 
and 4.7 Hz), 2.82 (1H, dd, J 16.5 and 6.4 Hz), 2.75 (1H, d, J 17.0 
Hz) and 2.68 (1H, d, J 17.0 Hz). 1H-NMR [500 MHz, (CD
3
)
2
SO)]: δ 
7.95 (1H, br s), 7.28 (1H, br s), 6.28 (1H, br s), 3.88 (1H, br t), 2.92 
(1H, dd, J 16.2 and 4.3 Hz), 2.71 (1H, dd, J 16.8 and 6.1 Hz), 2.60 
(1H, d, J 16.5 Hz) and 2.45 (1H, d, J 16.5 Hz). 13C-NMR [125 MHz, 
CD
3
OD]: δ 190.7, 177.1, 150.7, 125.5, 76.4, 61.9, 45.6 and 41.6. 
13C-NMR [125 MHz, (CD
3
)
2
SO)]: δ 189.0, 172.8, 150.1, 122.5, 74.2, 
58.7, 43.7 and 39.8. HRMS (ESI, m/z): calcd. for C
8
H
9
NO
3
Br - MH+, 
245.9766; found: 245.9742.
Analytical data for 7-Bromo-3a-hydroxy-2,3,3a,6,7,7a-he-
xahydro-1H-2,6-indoledione (8): IR (film, cm-1): 3269, 2979, 2925, 
1685, 1396, 1244, 1097 and 1049. 1H-NMR (300 MHz, (CD
3
)
2
CO): 
δ [7.71 (br s) and 7.23 (br s) 1H], 7.01 (d, J 10.3 Hz) and 6.88 (d, 
J 10.3 Hz), 1H], [6.16 (d, J 10.3 Hz) and 6.11 (d, J 10.3 Hz) 1H], 
[5.42 (br s) and 5.33 (br s), 1H], [5.12 (d, J 4.0 Hz) and 5.08 (d, J 9.9 
Hz), 1H], [4.42 (br d, J 4.0 Hz) and 4.16 (dd, J 10.1 and 1.5 Hz) 1H], 
[2.87 (d, J 16.8 Hz) and 2.70 (d, J 16.8 Hz), 1H] and [2.61 (d, J 16.8 
Hz) and 2.47 (d, J 16.8 Hz), 1H]. 13C-NMR [75 MHz, (CD
3
)
2
CO)]: 
δ 190.0, 189.5, 173.8, 173.5, 149.7, 148.7, 125.8, 125.7, 75.0, 73.5, 
69.6, 65.2, 58.5, 54.3, 45.4 and 43.5.
CONCLUSIONS
In this work, we have described the preparation of (+/-)-3-bromo-
verongiaquinol (1) in 50% overall yield from 1,4-benzoquinone (3), 
a more efficient approach than the one previously described in the 
literature. The first total synthesis of (+/-)-5-monobromocavernicolin 
(2) in 11% overall yield from 1,4-benzoquinone (3) was also des-
cribed, thus confirming the relative configuration assigned by Pietra 
and coworkers. Additionally, it was demonstrated that 5-monobro-
mocavernicolin (2) can be prepared in 13% yield (or 25% based on 
recovered starting material) from 3-bromoverongiaquinol (1) giving 
support to a conceivable biogenetic origin of (+/-)-2 from (+/-)-1.
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